Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Agenus Inc
(NQ:
AGEN
)
5.800
+0.330 (+6.03%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Agenus Inc
< Previous
1
2
3
4
5
6
7
8
Next >
Agenus Announces Preclinical Data on BMS-986442 (AGEN1777) at AACR 2024
March 06, 2024
From
Agenus Inc.
Via
Business Wire
Agenus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 05, 2024
From
Agenus Inc.
Via
Business Wire
Agenus to Provide Corporate Update and Fourth Quarter & Full Year 2023 Financial Report
February 29, 2024
From
Agenus Inc.
Via
Business Wire
Agenus to Participate in Leerink Partners Global Biopharma Conference
February 26, 2024
From
Agenus Inc.
Via
Business Wire
Agenus's Earnings Outlook
November 06, 2023
Via
Benzinga
Why Agenus Stock Plummeted by Nearly 30% on Its Stock Split News Today
February 15, 2024
The company hopes to engineer a 1-for-20 reverse stock split.
Via
The Motley Fool
12 Health Care Stocks Moving In Thursday's Intraday Session
February 15, 2024
Via
Benzinga
7 Analyst-Backed Stocks With Promising 10-Bagger Potential
February 01, 2024
Although true 10-baggers are by nature extremely difficult to come by, these analyst-backed stocks may offer a decent shot.
Via
InvestorPlace
Agenus to Participate in Oppenheimer 34th Annual Healthcare Life Sciences Conference
January 31, 2024
From
Agenus Inc.
Via
Business Wire
3 Biotech Stocks with Potential for Major Medical Breakthroughs in 2024
January 26, 2024
There are several potential biotech breakthroughs likely to occur in 2024, and these three biotech stocks could see substantial gains
Via
InvestorPlace
Botensilimab/Balstilimab Breakthrough Data Presented at ASCO-GI Shows Unprecedented Tumor Shrinkage and Robust Biomarker Response in Prevalent Colorectal Cancer Population
January 22, 2024
From
Agenus Inc.
Via
Business Wire
Why LQR House Shares Are Trading Higher By Around 16%; Here Are 20 Stocks Moving Premarket
January 16, 2024
Shares of LQR House Inc. (NASDAQ: LQR) rose sharply in pre-market trading. Borg's investor group has acquired a 20% stake in LQR House. LQR House shares jumped 16.1% to $4.25 in pre-market trading Here...
Via
Benzinga
Agenus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 05, 2024
From
Agenus Inc.
Via
Business Wire
Agenus to Participate in B. Riley Healthcare Conference
January 04, 2024
From
Agenus Inc.
Via
Business Wire
2 Small Cap Stocks That Could Go Parabolic in 2024, According to Wall Street
December 24, 2023
These two biotech stocks could be poised for a trend reversal.
Via
The Motley Fool
Botensilimab/Balstilimab Data in Neoadjuvant Colorectal Cancer Selected for ASCO-GI 2024
December 20, 2023
From
Agenus Inc.
Via
Business Wire
Agenus to Receive $25 Million Milestone Payment from Bristol Myers Squibb for TIGIT-CD96 Bispecific Program
December 11, 2023
From
Agenus Inc.
Via
Business Wire
Agenus Reports Third Quarter 2023 Results
November 07, 2023
From
Agenus Inc.
Via
Business Wire
Agenus to Provide Third Quarter 2023 Financial Report and Corporate Update
October 26, 2023
From
Agenus Inc.
Via
Business Wire
Textainer Group, Roivant Sciences And Other Big Stocks Moving Higher In Monday's Pre-Market Session
October 23, 2023
U.S. stock futures traded lower this morning on Monday. Here are some big stocks recording gains in today’s pre-market trading session.
Via
Benzinga
Agenus Unveils New and Updated Botensilimab Data in Colorectal, Pancreatic, Lung, Melanoma, and Sarcoma
October 22, 2023
From
Agenus Inc.
Via
Business Wire
ESMO 2023: Agenus’ Botensilimab/Balstilimab Combination Delivers Durable Responses across Multiple Sarcoma Subtypes
October 21, 2023
From
Agenus Inc.
Via
Business Wire
Agenus Completes Enrollment in Randomized Phase 2 Clinical Trial of Botensilimab/Balstilimab in Advanced Colorectal Cancer
October 10, 2023
From
Agenus Inc.
Via
Business Wire
Agenus To Host BOT/BAL Program Update at ESMO 2023
October 05, 2023
From
Agenus Inc.
Via
Business Wire
Agenus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 01, 2023
From
Agenus Inc.
Via
Business Wire
HEICO, Canaan And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
August 29, 2023
U.S. stock futures traded higher this morning on Tuesday. Here are some big stocks recording losses in today’s pre-market trading session. HEICO Corporation (NYSE: HEI) shares tumbled 5.3% to $159.01...
Via
Benzinga
3 Magnificent Growth Stocks to Buy on the Dip
August 28, 2023
These three biotech stocks are attractive buys right now.
Via
The Motley Fool
Agenus to Participate in September Investor Conferences
August 28, 2023
From
Agenus Inc.
Via
Business Wire
Agenus Prioritizes Resources to Accelerate Registration and Commercialization of BOT/BAL Program in Multiple Cancers
August 23, 2023
From
Agenus Inc.
Via
Business Wire
12 Health Care Stocks Moving In Friday's Intraday Session
August 18, 2023
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.